Parnell Pharmaceuticals Holdings Ltd Company Profile (NASDAQ:PARN)

Analyst Ratings

Consensus Ratings for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (681.25% upside)

Analysts' Ratings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Show:
DateFirmActionRatingPrice TargetActions
5/24/2016Dawson JamesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Jefferies GroupReiterated RatingBuy$18.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016Piper Jaffray Cos.Reiterated RatingOverweight$12.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/9/2016        
10/21/2015Q3($0.22)($0.13)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2015Q2($0.26)($0.19)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
DateHeadline
07/26/16 06:02 PMNew Broker Ratings For Parnell Pharmaceuticals Holdings Ltd (PARN) - FTSE News
07/26/16 06:02 PMParnell Pharmaceuticals Holdings Ltd.: Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on ... - The Wall Street Transcript
07/26/16 04:18 PMParnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 - [at noodls] - OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing ...
07/25/16 10:07 AMIs $16.11 Price Target Attainable For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)? - Investor Newswire
07/23/16 09:38 AMEarnings Focus and Crowd Sourced Sentiment Review for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - TGP
07/21/16 06:01 PMParnell Pharmaceuticals Holdings Ltd. Stock Technicals Hit Extreme Weakness - CML News
07/19/16 05:52 PMEquity Roundup: Stock Performance Focus on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph
07/17/16 05:06 PMStrong Sell Calls For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) At 0 - Investor Newswire
07/14/16 09:17 AMParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 05:57 PMTrading Performance and Target Watch for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph
07/11/16 05:44 PMCompany Stock Focus for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN): Which Way Will Shares Head? - Press Telegraph
07/10/16 05:02 PMIs $16.11 Within Reach For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)? - Investor Newswire
07/07/16 08:37 AMCan Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Improve on the Earnings Front? - Engelwood Daily
07/07/16 08:37 AMParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/07/16 08:37 AMStock Rating Watch and Earnings Insight for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph
07/04/16 04:59 PMParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Expected to Reach Highs Of $16 - Investor Newswire
07/02/16 05:23 PMKruuda on Poola rallil avapäeva järel oma klassis esimene, Pärn kolmas - Postimees
07/02/16 05:23 PMVictory for Priit Pärn Who Will Continue Teaching At Estonian Academy of Arts - Cartoon Brew
07/01/16 05:44 PMSuper Special stage opener in Poland classification
07/01/16 05:44 PMVictory for Priit Pärn Who Will Continue Teaching At Estonian Academy of Arts
06/30/16 05:58 PMParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Company Rating and Target Watch - Telanagana Press
06/29/16 08:32 AMParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Earnings Glance and Target Price Review - Engelwood Daily
06/29/16 08:32 AMParnell Pharmaceuticals Holdings Ltd (PARN) Broker Price Targets For The Coming Week - Fiscal Standard
06/29/16 08:32 AMShare Update and Earnings Review for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph
06/26/16 04:52 PMParnell Pharmaceuticals Holdings Ltd (PARN) Updated Price Targets - FTSE News
06/26/16 04:52 PMStrong Sell Calls Recommendations For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) At 0 - Investor Newswire
06/20/16 07:19 AMThis Weeks Broker Views For Parnell Pharmaceuticals Holdings Ltd (PARN) - Fiscal Standard
06/20/16 07:19 AMStrong Buy Calls Count For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) At 2 - Investor Newswire
06/13/16 08:41 AMTrend Of Rating Given To Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Investor Newswire
06/02/16 08:44 AMBuy, Sell Or Hold Rating For Parnell Pharmaceuticals Holdings Ltd (PARN)? - Share Trading News - Kansas City Business JournalBuy, Sell Or Hold Rating For Parnell Pharmaceuticals Holdings Ltd (PARN)?Share Trading News02/29/2016 – Parnell Pharmaceuticals Holdings Ltd had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 9 price target on the stock. 07/14/2014 – Ladenburg Thalmann began new coverage on Parnell Pharmaceuticals ...Traders Are Bearish Parnell Pharmaceuticals Holdings Ltd After The Stock Formed Double Bottom PatternThe PostParnell Pharmaceuticals Enters Contract Manufacturing Deal with Sanofi's Merial (NASDAQ:PARN)Sonoran Weekly ReviewActinium (NYSEMKT:ATNM) announces 'positive' results from its Phase 1 Actimab-A trial: Galena Biopharma (NASDAQ ...Benchmark Monitorall 9 news articles »
06/01/16 08:40 AMParnell Pharmaceuticals Holdings Ltd (PARN) Receives “Buy” Rating from Dawson James - Let Me Know About This - Parnell Pharmaceuticals Holdings Ltd (PARN) Receives “Buy” Rating from Dawson JamesLet Me Know About ThisParnell Pharmaceuticals Holdings logo Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)'s stock had its “buy” rating reaffirmed by equities researchers at Dawson James in a research report issued to clients and investors on Tuesday. Shares of Parnell ...After Last Week What Do Analysts Think Of Parnell Pharmaceuticals Holdings Ltd (PARN)Share Trading NewsParnell Pharmaceuticals Holdings (NASDAQ:PARN) Short Interest Increased By 43.38%The Postall 3 news articles »
06/01/16 08:40 AMStock Review and Earnings Check on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - HNN - Stock Review and Earnings Check on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)HNNCurrently, sell-side analysts are expecting Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) to report quarterly EPS of $N/A. The company's next earnings report is expected to be published on or around 2016-04-22 for the period ending on 2016-03-31 ...and more »
06/01/16 08:40 AMParnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial - GlobeNewswire (press release) - Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with MerialGlobeNewswire (press release)OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal ...Parnell Pharmaceuticals Enters Contract Manufacturing Deal with Sanofi's Merial (NASDAQ:PARN)Sonoran Weekly Reviewall 2 news articles »
05/31/16 06:01 PMBRIEF-Parnell Pharmaceuticals says manufacturing deal with Merial - Reuters - BRIEF-Parnell Pharmaceuticals says manufacturing deal with MerialReutersJune 1 Parnell Pharmaceuticals Holdings Ltd. * Parnell Pharmaceuticals Holdings announces contract manufacturing agreement with Merial. * Estimates total value of deal between $7 million and $20 million depending on volume of product purchased by ...
05/31/16 06:01 PMParnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial - Nasdaq - Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with MerialNasdaqOVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal ...and more »
05/31/16 03:13 PMParnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial - [at noodls] - OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing ...
05/30/16 06:45 PMStock Rating Review for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - HNN - Stock Rating Review for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)HNNCovering equity analysts presently have a consensus stock rating of 1 on shares of Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research.and more »
05/30/16 06:45 PMParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Impact Score At 0 - Stocks Daily - Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Impact Score At 0Stocks DailyAlpha One explored various online articles released on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), and it set a daily sentiment score of 0.046 on the company. The entity has an algorithm in place to know stock sentiment on the share after ...and more »
05/30/16 06:45 PMAfter Last Week What Do Analysts Think Of Parnell Pharmaceuticals Holdings Ltd (PARN) - Share Trading News - After Last Week What Do Analysts Think Of Parnell Pharmaceuticals Holdings Ltd (PARN)Share Trading News07/14/2014 – JMP Securities began new coverage on Parnell Pharmaceuticals Holdings Ltd giving the company a “outperform” rating. They now have a USD 12 price target on the stock. The share price of Parnell Pharmaceuticals Holdings Ltd (PARN) was ...Parnell Pharmaceuticals Holdings Ltd (PARN) Receives “Buy” Rating from Dawson JamesLet Me Know About ThisParnell Pharmaceuticals Holdings (NASDAQ:PARN) Short Interest Increased By 43.38%The Postall 3 news articles »
05/23/16 02:30 PMPARN: Manufacturing Contract Set to Be Signed; Zydax® Approval Likely by the First Quarter of 2017… -
05/12/16 09:15 AMParnell Pharma Gears Up for Secondary Offering -
04/22/16 06:38 AMParnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update - Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) , a fully integrated, commercial-stage ...
03/15/16 01:39 PMWhat Is The ABR Of Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)? - Investor Newswire - What Is The ABR Of Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)?Investor NewswireZacks Research has reported Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) to have ABR of 1. Investors always look out to invest in the companies that are considered as best performing in the industry. A group of investors acknowledges the value ...and more »
03/15/16 01:39 PMUpdated Price Targets On Parnell Pharmaceuticals Holdings Ltd (PARN) - Risers & Fallers - Updated Price Targets On Parnell Pharmaceuticals Holdings Ltd (PARN)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Parnell Pharmaceuticals Holdings Ltd (PARN). The latest broker reports which are currently outstanding on Tuesday 15th of March state 2 analysts have a rating of “strong ...Zacks: Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Receives Consensus Recommendation of "Strong Buy ...The Hilltop Newsall 2 news articles »
03/07/16 11:25 AMPARN: Initiating Coverage of Parnell Pharmaceuticals Holdings Ltd.; A Fully Integrated Animal Specialty Pharmaceutical Company -
02/28/16 01:54 PMRevenue Update on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - SCSUCollegian - Revenue Update on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)SCSUCollegianParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) announced the earnings results for Fiscal Year 2015 and Q4. The results came in during Pre-market on Feb 24, 2016. Company reported revenue of $3.37M. Analysts estimated a revenue of $3.95M.
02/26/16 09:12 AMParnell Pharmaceuticals Holdings (NASDAQ:PARN) Short Interest Decreased By 55.86% - Business Standard Tribune - Parnell Pharmaceuticals Holdings (NASDAQ:PARN) Short Interest Decreased By 55.86%Business Standard TribuneThe short interest to Parnell Pharmaceuticals Holdings's float is 0.15%. The stock is up 1.84% or $0.05 after the news, hitting $2.77 per share. About 86,937 shares traded hands or 92.62% up from the average. Parnell Pharmaceuticals Holdings Ltd ...
02/26/16 09:12 AMParnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015 - GlobeNewswire (press release) - Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015GlobeNewswire (press release)24, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today ...Recent Broker Updates On Parnell Pharmaceuticals Holdings Ltd (PARN)Risers & FallersParnell Pharmaceuticals Holdings Ltd (PARN) to Release Earnings on WednesdayFinancial Market NewsDoes Parnell Pharmaceuticals Holdings Ltd Have Any Gas After Today's Huge Decline?RiversideGazette.comThe Vista Voiceall 20 news articles »
02/25/16 10:03 AMParnell Pharmaceuticals Holdings Ltd. Earnings Analysis: 2015 By the Numbers -
02/25/16 07:04 AMEdited Transcript of PARN earnings conference call or presentation 24-Feb-16 1:00pm GMT -

Social

About Parnell Pharmaceuticals Holdings Ltd

Parnell Pharmaceuticals Holdings Ltd logoParnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PARN
  • CUSIP:
Key Metrics:
  • Previous Close: $1.60
  • 50 Day Moving Average: $1.53
  • 200 Day Moving Average: $2.13
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $21.25M
  • Beta: -0.27
  • Current Year EPS Consensus Estimate: $-1.76 EPS
  • Next Year EPS Consensus Estimate: $-1.54 EPS
Additional Links:
Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Chart for Saturday, July, 30, 2016